Last Update 17:52
Monday, 22 July 2019

Egypt's Sisi objects to clinical trials draft law

Ahram Online, Tuesday 2 Oct 2018
Sisi
File Photo: Egypt's President Abdel Fattah El-Sisi (Photo: Reuters)
Share/Bookmark
Views: 4180
Share/Bookmark
Views: 4180

Egypt's President Abdel-Fattah El-Sisi has sent a letter to the House of Representatives expressing his objection to some articles of a draft law on clinical trials, which governs the organisation of medical research in Egypt.

The draft law was passed last May and has raised ethical and legal concerns among medical researchers.

"Some of the most controversial articles of this law have sparked serious reactions and divided public opinion into either strong sceptics or feverish supporters," said El-Sisi's letter, adding that "the president's office has also received important remarks from some scientific and professional circles and all indicate that some of the law's articles are still a matter of severe controversy."

El-Sisi's letter said articles 4, 5, 9, 11, 19, 20, and 22 need a new debate that takes all different points of view into consideration.

House Speaker Ali Abdel-Aal praised the president's comments on the law, saying that they reflect an active political life and atmosphere in the country.

Abdel-Aal noted that this is the second time in the country's history – and the first time for the current parliament – that the president has objected to a draft law approved by parliament.

The president urged parliament to reconsider the draft law. 

The clinical trial law, which consists of 18 articles, was first discussed by parliament in 2006, but was suspended after public backlash.

Clinical trials are tests conducted on human volunteers to evaluate the effectiveness and safety of newly developed medications or medical devices.

Egypt has been witnessing a steady increase in the number of trials it hosts, which has pushed parliament to discuss this law, potentially putting restrictions on experiments that are conducted in hospitals. 

In February 2016, there were 57 active clinical drug trials, half of which were to assess cancer treatments, according to the independent Egyptian Initiative for Personal Rights (EIPR).

Short link:

 

Email
 
Name
 
Comment's
Title
 
Comment
Ahram Online welcomes readers' comments on all issues covered by the site, along with any criticisms and/or corrections. Readers are asked to limit their feedback to a maximum of 1000 characters (roughly 200 words). All comments/criticisms will, however, be subject to the following code
  • We will not publish comments which contain rude or abusive language, libelous statements, slander and personal attacks against any person/s.
  • We will not publish comments which contain racist remarks or any kind of racial or religious incitement against any group of people, in Egypt or outside it.
  • We welcome criticism of our reports and articles but we will not publish personal attacks, slander or fabrications directed against our reporters and contributing writers.
  • We reserve the right to correct, when at all possible, obvious errors in spelling and grammar. However, due to time and staffing constraints such corrections will not be made across the board or on a regular basis.
Latest

© 2010 Ahram Online.